Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Cynthia M Rohde

2PUBLICATIONS

3CO-AUTHORS

Nanotoxicology, health and safetyInnate immunity

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Oct 30, 2024

Are Repeat-Dose Toxicity Studies Informative for Safety Assessment of Vaccine Candidates? A Survey of Vaccine Developers.

Cynthia M Rohde, Eric Destexhe, Jan Willem van der Laan

|Oct 07, 2024

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines.

Teresa Hauguel, Amy Sharma, Emily Mastrocola

Pageof 1

Frequent Collaborators

1 joint publications

Swati Rajput

1 joint publications

Allison Vitsky

1 joint publications

Annaliesa S Anderson

Frequent Collaborators

1 joint publications

Swati Rajput

1 joint publications

Allison Vitsky

1 joint publications

Annaliesa S Anderson

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos

Top Related Videos

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Rapid <em>In Vivo</em> Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on : Jun 19, 2018

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

See more related videos